Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Gut Health: Since the compound originates from the gastrointestinal tract, some use it to address conditions like leaky gut or inflammatory bowel issues
FOXO4-DRI is among the highest-risk research peptides from an evidence-to-risk standpoint: it has never been tested in humans, no human pharmacokinetic data exists, and as a senolytic it carries theoretical risks specific to its mechanism
We carry bacteriostatic water on the site so research supplies can be ordered together when needed
Sermorelin was previously FDA-approved under the brand name Geref, both as a diagnostic agent for GH deficiency (Geref Diagnostic, approved 1997) and as a therapeutic agent for pediatric idiopathic GH deficiency
Restorative Compounding, for example, licensed in 38 states, offers: API integration eRx eFax provider portal submission Match the integration to your EHRs capabilities
Human clinical applications are unproven
US$ 25.74
US$ 21.86
US$ 21.98
US$ 22.34
US$ 24.75
US$ 26.25
